Ahmed, A., Elmantwe, A., Helal, A., Sabra, A., Elbanhawy, H., Darwish, F. (2024). Is an enlarged fibroid uterus a contraindication for Non-Descent Vaginal Hysterectomy (NDVH)? Retrospective comparison between cohort whose uterine size ≥ 12 weeks and cohort whose uterine size less than 12 weeks underwent NDVH.. test, 41(4), 136-151. doi: 10.21608/bmfj.2024.243409.1928
ahmed mousad baioumy Ahmed; Ashraf nassif Elmantwe; Ahmed Gamal Goda Helal; Ahmed Sabra Ibrahim Mohammed Sabra; Hossam Elbanhawy; Fatma Faisal Ibrahim Darwish. "Is an enlarged fibroid uterus a contraindication for Non-Descent Vaginal Hysterectomy (NDVH)? Retrospective comparison between cohort whose uterine size ≥ 12 weeks and cohort whose uterine size less than 12 weeks underwent NDVH.". test, 41, 4, 2024, 136-151. doi: 10.21608/bmfj.2024.243409.1928
Ahmed, A., Elmantwe, A., Helal, A., Sabra, A., Elbanhawy, H., Darwish, F. (2024). 'Is an enlarged fibroid uterus a contraindication for Non-Descent Vaginal Hysterectomy (NDVH)? Retrospective comparison between cohort whose uterine size ≥ 12 weeks and cohort whose uterine size less than 12 weeks underwent NDVH.', test, 41(4), pp. 136-151. doi: 10.21608/bmfj.2024.243409.1928
Ahmed, A., Elmantwe, A., Helal, A., Sabra, A., Elbanhawy, H., Darwish, F. Is an enlarged fibroid uterus a contraindication for Non-Descent Vaginal Hysterectomy (NDVH)? Retrospective comparison between cohort whose uterine size ≥ 12 weeks and cohort whose uterine size less than 12 weeks underwent NDVH.. test, 2024; 41(4): 136-151. doi: 10.21608/bmfj.2024.243409.1928

Is an enlarged fibroid uterus a contraindication for Non-Descent Vaginal Hysterectomy (NDVH)? Retrospective comparison between cohort whose uterine size ≥ 12 weeks and cohort whose uterine size less than 12 weeks underwent NDVH.

Benha Medical Journal
Article 13, Volume 41, Issue 4, July and August 2024, Pages 136-151    PDF (984.34 K)
Document Type: Original Article
DOI: 10.21608/bmfj.2024.243409.1928
Authors
ahmed mousad baioumy Ahmed1; Ashraf nassif Elmantwe* 2; Ahmed Gamal Goda Helal3; Ahmed Sabra Ibrahim Mohammed Sabra4; Hossam Elbanhawy5; Fatma Faisal Ibrahim Darwish6
1benha university
2Benha faculty of medicine
3Obstetrics & Gynecology Benha Faculty of Medicine Benha University Egypt
4Obstetrics and gynecology, Benha Faculty of Medicine, Benha university
5Teaching Hospitals Organization
6obstetrics and gynecology, Al-Qasr Al-Aini, Cairo University Egypt
Abstract
Background: An enlarged fibroid uterus greater than 12 weeks is considered a contraindication for Non-Descent Vaginal Hysterectomy (NDVH) by most gynecologic surgeons, is this contraindication real or alleged?
Aim: to evaluate the impact of uterine size on perioperative consequences in women who underwent NDVH for benign conditions.
Patients and Methods: Of 340 women underwent NDVH, 232 women had uterine sizes up to 12 weeks (control group), and 108 women who had uterine sizes more than 12 and up to 24 weeks (index group).
Results: Both groups were similar regards menopausal, nulliparity status, number of prior vaginal birth, preoperative medical status, and American Society of Anesthesiologists grades (P>0.05), but different in percentage of women with fibroids, cervical pathology, prior Cesarean section, and virgin lower abdomen(P0.05). However, the effect of uterine size larger than 12 weeks in comparison to uterine size up to 12 weeks was significant on the subsequent outcomes total operative time (55 minutes) operative blood loss (160 ml), needs for general anesthesia, needs for debunking, needs for analgesics, decline in PO HB, and return to usual activity(P
Keywords
fibroids; vaginal hysterectomy; NDVH; enlarged fibroid uterus; perioperative consequences
Statistics
Article View: 170
PDF Download: 235